Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1987 Apr;25(4):600–604. doi: 10.1128/jcm.25.4.600-604.1987

Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays.

D C Classen, J M Morningstar, J D Shanley
PMCID: PMC266042  PMID: 3033015

Abstract

We have compared murine cytomegalovirus (MCMV) antibody determination by enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence assay. A comparison of antibody detection with 146 serum samples at a 1:20 dilution showed 100% agreement (60 negatives and 86 positives) between the assays. There was close agreement of endpoint determinations of sera by both methods. After experimental MCMV infection, antibody to MCMV was detected by both assays as early as day 7, and high titers persisted as late as 6 months. In contrast to immunocompetent littermates, athymic nude mice did not develop antibody after infection. Mice lacking antibody detectable by ELISA were susceptible to lethal MCMV challenge. In a survey of animals from five commercial sources, MCMV antibody was not detected unless mice were experimentally infected. MCMV antibody determination by ELISA is a convenient method, comparable to the indirect immunofluorescence assay in sensitivity and specificity.

Full text

PDF
600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. A., Murphy J. C., Fox J. G. Evaluation of murine cytomegalovirus antibody detection by serological techniques. J Clin Microbiol. 1983 Oct;18(4):753–758. doi: 10.1128/jcm.18.4.753-758.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson C. A., Murphy J. C., Fox J. G. Surveillance of mice for antibodies to murine cytomegalovirus. J Clin Microbiol. 1986 Jun;23(6):1152–1154. doi: 10.1128/jcm.23.6.1152-1154.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chong K. T., Gould J. J., Mims C. A. Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage. Arch Virol. 1981;69(2):95–104. doi: 10.1007/BF01315153. [DOI] [PubMed] [Google Scholar]
  4. Cremer N. E., Schmidt N. J., Jensen F., Hoffman M., Oshiro L. S., Lennette E. H. Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol. 1975 Mar;1(3):262–267. doi: 10.1128/jcm.1.3.262-267.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Griffiths P. D., Buie K. J., Heath R. B. A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies. J Clin Pathol. 1978 Sep;31(9):827–831. doi: 10.1136/jcp.31.9.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Horodniceanu F., Michelson S. Assessment of human cytomegalovirus antibody detection techniques. Arch Virol. 1980;64(4):287–301. doi: 10.1007/BF01320614. [DOI] [PubMed] [Google Scholar]
  7. Jordan M. C. Latent infection and the elusive cytomegalovirus. Rev Infect Dis. 1983 Mar-Apr;5(2):205–215. doi: 10.1093/clinids/5.2.205. [DOI] [PubMed] [Google Scholar]
  8. Kettering J. D., Schmidt N. J., Lennette E. H. Improved glycine-extracted complement-fixing antigen for human cytomegalovirus. J Clin Microbiol. 1977 Dec;6(6):647–649. doi: 10.1128/jcm.6.6.647-649.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kim K. S., Carp R. I. Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody. J Virol. 1973 Dec;12(6):1620–1621. doi: 10.1128/jvi.12.6.1620-1621.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kim K. S., Sapienza V. J., Carp R. I., Moon H. M. Analysis of structural proteins of purified murine cytomegalovirus. J Virol. 1976 Mar;17(3):906–915. doi: 10.1128/jvi.17.3.906-915.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Loh L., Hudson J. B. Murine cytomegalovirus infection in the spleen and its relationship to immunosuppression. Infect Immun. 1981 Jun;32(3):1067–1072. doi: 10.1128/iai.32.3.1067-1072.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mattsson D. M., Howard R. J., Balfour H. H., Jr Immediate loss of cell-mediated immunity to murine cytomegalovirus upon treatment with immunosuppressive agents. Infect Immun. 1980 Dec;30(3):700–708. doi: 10.1128/iai.30.3.700-708.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Plummer G. Cytomegaloviruses of man and animals. Prog Med Virol. 1973;15:92–125. [PubMed] [Google Scholar]
  14. Selgrade M. K., Ahmed A., Sell K. W., Gershwin M. E., Steinberg A. D. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol. 1976 May;116(5):1459–1465. [PubMed] [Google Scholar]
  15. Shanley J. D., Jordan M. C., Stevens J. G. Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis. 1981 Feb;143(2):231–237. doi: 10.1093/infdis/143.2.231. [DOI] [PubMed] [Google Scholar]
  16. Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945–949. doi: 10.1056/NEJM198204223061601. [DOI] [PubMed] [Google Scholar]
  17. Voller A., Bartlett A., Bidwell D. E. Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol. 1978 Jun;31(6):507–520. doi: 10.1136/jcp.31.6.507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES